InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Klassen Preston, 首席执行官. Director active across 3 companies, notably Metacrine, Inc.. Aggregated, 12 filings have been recorded. Split: 2 buys · 3 sells. Total volume traded: €348k. History available since 20 May 2021. The latest transaction was filed on 3 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Klassen Preston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
115,555 股Common StockSEC:0000950170-25-091020:0
12,000 股@ US$7.987748.8% 占其流量Common StockSEC:0000950170-25-081715:0
标准退出：2025年9月1日 (T+90)
31,445 股@ US$1.263244.0% 占其流量Common StockSEC:0000950170-25-005880:0
37,500 股@ US$1.3656.0% 占其流量Common StockSEC:0000950170-25-004269:0
842,211 股@ US$0.4756.0% 占其流量Common StockSEC:0001209191-23-020882:0
380,605 股@ US$0.413222.1% 占其流量Common StockSEC:0001209191-23-005271:0
43,575 股@ US$0.502114.2% 占其流量Common StockSEC:0001209191-22-024951:0
104,500 股0Common StockSEC:0001209191-22-024631:0
842,211 股0Common StockSEC:0001209191-22-014081:0
20,547 股@ US$3.635210.4% 占其流量Common StockSEC:0001209191-21-034596:0
标准退出：2021年8月18日 (T+90)
1,860 股Common StockSEC:0001209191-16-095647:0
4,170 股Common StockSEC:0001209191-16-095647:1
12 条申报中的 12 条
About Klassen Preston
Klassen Preston is Directeur Général. He has 12 filings in total, and in the recent sample covered, the reported transactions run from 2016-02-04 to 2025-06-27, with EUR 145292 of purchases and EUR 203032 of sales. His recent filings concern Metacrine, Inc., Regulus Therapeutics Inc. and Orexigen Therapeutics, Inc., and the most frequent transaction nature is Attribution.
